Skip to main content
Clinical Trials/CTRI/2023/01/049054
CTRI/2023/01/049054
Completed
Phase 2

Randomised controlled clinical trial to compare the efficacy of Shatavari Mulaasava and Shatavari Churna in the management of Nidranasha.

Dr Ravina Nagesh Dalvi0 sites58 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Health Condition 1: G470- Insomnia
Sponsor
Dr Ravina Nagesh Dalvi
Enrollment
58
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
March 19, 2024
Last Updated
2 years ago
Study Type
Interventional

Investigators

Sponsor
Dr Ravina Nagesh Dalvi

Eligibility Criteria

Inclusion Criteria

  • 1\. Patients suffering from Insomnia since 6 months. 2\. Patients showing mild to moderate symptoms of Insomnia. 3\. Patients having Insomnia severity index score between 8 to 21\.

Exclusion Criteria

  • 1\. Patients having history of any comorbidities along with Insomnia. 2\. Patients having history of any chronic psychological conditions. 3\. Pregnant and lactating mothers. 3\. Patients suffering from diabetes mellitus.

Outcomes

Primary Outcomes

Not specified

Similar Trials